Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Ethicon launch of ThermaChoice uterine balloon backed by direct sales force of roughly 60 reps.

This article was originally published in The Gray Sheet

Executive Summary

ETHICON's LAUNCH OF THERMACHOICE UTERINE BALLOON THERAPY SYSTEM is being backed by a roughly 60-rep sales force specializing in women's health products. J&J began selling the device to U.S. gynecologists immediately following FDA approval Dec. 12.

You may also be interested in...



Gynecologists Likely To Have New Options For Treating Menorrhagia In 2001

BEI Medical Systems' Hydro ThermAblator (HTA) system for endometrial ablation will provide a new option for gynecologists in the treatment of menorrhagia when it becomes available, likely in early 2001.

Gynecologists Likely To Have New Options For Treating Menorrhagia In 2001

BEI Medical Systems' Hydro ThermAblator (HTA) system for endometrial ablation will provide a new option for gynecologists in the treatment of menorrhagia when it becomes available, likely in early 2001.

Ablation Versus Hysterectomy For Menorrhagia Achieves Cost Savings

Performing endometrial ablation in lieu of hysterectomy for treatment of dysfunctional uterine bleeding (DUB) can provide savings in the managed care setting, according to a recent study published in the American Journal of Managed Care.

Related Content

UsernamePublicRestriction

Register

MT009320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel